Analyst Reco. Afya Limited

Equities

AFYA

KYG011251066

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
19.39 ^USD	+1.31%		+6.13%	-11.58%

May. 10	Afya Q1 Adjusted Net Income, Revenue Advance; 2024 Outlook Reiterated	MT
May. 10	Earnings Flash (AFYA) AFYA LIMITED Posts Q1 Adjusted EPS BRL2.74	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Downgrades Afya to Neutral From Overweight, Adjusts Price Target to $23 From $22	Nov. 27	MT
Credit Suisse Adjusts Afya's Price Target to $18 From $19, Keeps Outperform Rating	22-11-22	MT
UBS Adjusts Afya Price Target to $18 From $21, Maintains Buy Rating	22-10-13	MT
Credit Suisse Upgrades Afya to Outperform from Neutral, Adjusts Price Target to $19 from $18	22-04-08	MT
UBS Adjusts Afya Price Target to $21 From $27, Maintains Buy Rating	22-03-07	MT
Goldman Sachs Adjusts Afya's Price Target to $19 From $29, Reiterates Buy Rating	22-02-15	MT
Afya : Sustainalytics ESG Risk Rating Is Publicly Available	21-09-28	BU
Afya : Sustainalytics ESG Risk Rating is Publicly Available	21-09-28	PU
AFYA : Morgan Stanley Downgrades Afya to Equalweight from Overweight, Adjusts Price Target to $28.50 from $32	21-07-21	MT
AFYA : UBS Upgrades Afya to Buy From Neutral, Citing Recent Sell-Off, Resiliency, Cash Generation; Price Target to $27 From $29.50	21-04-15	MT
AFYA : JPMorgan Upgrades Afya to Overweight From Neutral; Price Target is $34	21-02-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW